Peak Financial Advisors LLC Makes New Investment in Danaher Corporation $DHR

Key Points

• Peak Financial Advisors LLC has acquired a new position in Danaher Corporation, purchasing 2,431 shares valued at approximately $480,000.
• Danaher recently announced a quarterly dividend of $0.32 per share, with an annualized yield of 0.7%, set to be paid on October 31st to investors of record.
• Analysts have varying price targets for Danaher stock, with estimates ranging from $225.00 to $275.00, reflecting a consensus "Moderate Buy" rating among seventeen analysts.

Peak Financial Advisors LLC bought a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,431 shares of the conglomerate's stock, valued at approximately $480,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Bank Pictet & Cie Europe AG boosted its position in shares of Danaher by 22.8% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after acquiring an additional 35,730 shares in the last quarter. ProShare Advisors LLC boosted its position in shares of Danaher by 12.2% during the 4th quarter. ProShare Advisors LLC now owns 98,720 shares of the conglomerate's stock worth $22,661,000 after acquiring an additional 10,770 shares in the last quarter. Silvercrest Asset Management Group LLC boosted its position in shares of Danaher by 0.3% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 116,682 shares of the conglomerate's stock worth $26,784,000 after acquiring an additional 328 shares in the last quarter. Tema Etfs LLC acquired a new stake in shares of Danaher during the 4th quarter worth approximately $1,577,000. Finally, Strategic Wealth Partners Ltd. boosted its position in shares of Danaher by 14.4% during the 4th quarter. Strategic Wealth Partners Ltd. now owns 1,502 shares of the conglomerate's stock worth $345,000 after acquiring an additional 189 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on DHR shares. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research report on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft cut their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. UBS Group cut their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a research report on Friday, July 11th. Finally, Evercore ISI cut their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $246.35.

Danaher Price Performance

DHR stock opened at $190.07 on Friday. The company has a fifty day moving average price of $201.21 and a 200-day moving average price of $198.83. The company has a market capitalization of $136.10 billion, a P/E ratio of 40.44, a PEG ratio of 2.72 and a beta of 0.75. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's dividend payout ratio (DPR) is currently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.